Ambac Financial Group Inc AMBC
We take great care to ensure that the data presented and summarized in this overview for AMBAC FINANCIAL GROUP INC is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding AMBC
View all-
Black Rock Inc. New York, NY7.46MShares$56.4 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.66MShares$20.1 Million0.0% of portfolio
-
Dimensional Fund Advisors LP Austin, TX2.56MShares$19.3 Million0.01% of portfolio
-
Susquehanna International Group, LLP Bala Cynwyd, PA1.18MShares$8.93 Million0.0% of portfolio
-
Repertoire Partners LP New York, NY1.17MShares$8.87 Million4.54% of portfolio
-
Bain Capital Credit, LP Boston, MA1.11MShares$8.38 Million2.36% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il1.1MShares$8.34 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA1.09MShares$8.28 Million0.0% of portfolio
-
State Street Corp Boston, MA1.03MShares$7.8 Million0.0% of portfolio
-
Morgan Stanley New York, NY858KShares$6.49 Million0.0% of portfolio
Latest Institutional Activity in AMBC
Top Purchases
Top Sells
About AMBC
Ambac Financial Group, Inc., a financial services holding company, provides financial guarantees in the United States, the United Kingdom, Italy, Austria, Australia, France, and Internationally. It offers financial guarantee insurance policies; specialty property & casualty program insurance; credit derivative contracts; and interest rate derivative transactions, as well as managing general agency / underwriting services. The company was incorporated in 1991 and is headquartered in New York, New York.
Insider Transactions at AMBC
Insider Transaction List
View allDate | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
May 14
2025
|
Jeffrey Scott Stein Director |
BUY
Open market or private purchase
|
Direct |
15,000
+13.64%
|
$90,000
$6.47 P/Share
|
May 14
2025
|
Michael D Price Director |
BUY
Open market or private purchase
|
Direct |
76,986
+15.84%
|
$461,916
$6.52 P/Share
|
May 14
2025
|
Claude Le Blanc Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
40,000
+6.47%
|
$240,000
$6.5 P/Share
|
Mar 13
2025
|
R Sharon Smith Exec VP & Chief Strategy Offr |
SELL
Payment of exercise price or tax liability
|
Direct |
238
-0.32%
|
$1,904
$8.39 P/Share
|
Mar 13
2025
|
R Sharon Smith Exec VP & Chief Strategy Offr |
BUY
Exercise of conversion of derivative security
|
Direct |
238
+0.32%
|
-
|
Mar 13
2025
|
David Trick Exec VP, CFO & Treasurer |
SELL
Payment of exercise price or tax liability
|
Direct |
267
-0.17%
|
$2,136
$8.39 P/Share
|
Mar 13
2025
|
David Trick Exec VP, CFO & Treasurer |
BUY
Exercise of conversion of derivative security
|
Direct |
267
+0.17%
|
-
|
Mar 13
2025
|
Stephen Michael Ksenak Sr. MD & General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
1,703
-1.38%
|
$13,624
$8.39 P/Share
|
Mar 13
2025
|
Stephen Michael Ksenak Sr. MD & General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
4,726
+3.69%
|
-
|
Mar 13
2025
|
Claude Le Blanc Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
13,452
-2.44%
|
$107,616
$8.39 P/Share
|
Mar 13
2025
|
Claude Le Blanc Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
24,327
+4.22%
|
-
|
Mar 13
2025
|
Daniel Mc Ginnis Sr. MD & COO |
SELL
Payment of exercise price or tax liability
|
Direct |
94
-0.51%
|
$752
$8.39 P/Share
|
Mar 13
2025
|
Daniel Mc Ginnis Sr. MD & COO |
BUY
Exercise of conversion of derivative security
|
Direct |
94
+0.5%
|
-
|
Mar 13
2025
|
David Barranco Senior Managing Director |
SELL
Payment of exercise price or tax liability
|
Direct |
189
-0.15%
|
$1,512
$8.39 P/Share
|
Mar 13
2025
|
David Barranco Senior Managing Director |
BUY
Exercise of conversion of derivative security
|
Direct |
189
+0.15%
|
-
|
Mar 13
2025
|
Robert Bryan Eisman Sr. MD & CAO |
SELL
Payment of exercise price or tax liability
|
Direct |
687
-0.97%
|
$5,496
$8.39 P/Share
|
Mar 13
2025
|
Robert Bryan Eisman Sr. MD & CAO |
BUY
Exercise of conversion of derivative security
|
Direct |
1,908
+2.62%
|
-
|
Mar 06
2025
|
Daniel Mc Ginnis Sr. MD & COO |
SELL
Payment of exercise price or tax liability
|
Direct |
6,736
-26.74%
|
$60,624
$9.16 P/Share
|
Mar 06
2025
|
Daniel Mc Ginnis Sr. MD & COO |
BUY
Exercise of conversion of derivative security
|
Direct |
16,874
+40.11%
|
-
|
Mar 06
2025
|
David Barranco Senior Managing Director |
SELL
Payment of exercise price or tax liability
|
Direct |
7,379
-5.43%
|
$66,411
$9.16 P/Share
|
Last 12 Months Summary
Open market or private purchase | 290K shares |
---|---|
Grant, award, or other acquisition | 28.3K shares |
Exercise of conversion of derivative security | 73.5K shares |
Payment of exercise price or tax liability | 60K shares |
---|